Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland.
Department of Rheumatology, University Hospital, 3010 Bern, Switzerland.
Biomolecules. 2020 Oct 1;10(10):1399. doi: 10.3390/biom10101399.
In mammals, the novel protein fibroblast growth factor receptor-like 1 (FGFRL1) is involved in the development of metanephric kidneys. It appears that this receptor controls a crucial transition of the induced metanephric mesenchyme to epithelial renal vesicles, which further develop into functional nephrons. FGFRL1 knockout mice lack metanephric kidneys and do not express any fibroblast growth factor (FGF) 8 in the metanephric mesenchyme, suggesting that FGFRL1 and FGF8 play a decisive role during kidney formation. FGFRL1 consists of three extracellular immunoglobulin (Ig) domains (Ig1-Ig2-Ig3), a transmembrane domain and a short intracellular domain. We have prepared the extracellular domain (Ig123), the three individual Ig domains (Ig1, Ig2, Ig3) as well as all combinations containing two Ig domains (Ig12, Ig23, Ig13) in recombinant form in human cells. All polypeptides that contain the Ig2 domain (Ig123, Ig12, Ig23, Ig2) were found to interact with FGF8 with very high affinity, whereas all constructs that lack the Ig2 domain (Ig1, Ig3, Ig13) poorly interacted with FGF8 as shown by ELISA and surface plasmon resonance. It is therefore likely that FGFRL1 represents a physiological receptor for FGF8 in the kidney and that the ligand primarily binds to the Ig2 domain of the receptor. With Biacore experiments, we also measured the affinity of FGF8 for the different constructs. All constructs containing the Ig2 domain showed a rapid association and a slow dissociation phase, from which a K of 2-3 × 10 M was calculated. Our data support the hypothesis that binding of FGF8 to FGFRL1 could play an important role in driving the formation of nephrons in the developing kidney.
在哺乳动物中,新型蛋白成纤维细胞生长因子受体样 1(FGFRL1)参与后肾原基的发育。该受体似乎控制诱导的后肾间充质向肾上皮小囊的关键转变,进一步发育为功能性肾单位。FGFRL1 敲除小鼠缺乏后肾原基,在后肾间充质中不表达任何成纤维细胞生长因子(FGF)8,表明 FGFRL1 和 FGF8 在肾脏形成过程中起决定性作用。FGFRL1 由三个细胞外免疫球蛋白(Ig)结构域(Ig1-Ig2-Ig3)、一个跨膜结构域和一个短的细胞内结构域组成。我们已在人细胞中以重组形式制备了细胞外结构域(Ig123)、三个单独的 Ig 结构域(Ig1、Ig2、Ig3)以及包含两个 Ig 结构域的所有组合(Ig12、Ig23、Ig13)。所有含有 Ig2 结构域的多肽(Ig123、Ig12、Ig23、Ig2)都被发现与 FGF8 具有非常高的亲和力相互作用,而所有缺乏 Ig2 结构域的构建体(Ig1、Ig3、Ig13)与 FGF8 的相互作用较差,如 ELISA 和表面等离子体共振法所示。因此,FGFRL1 很可能是肾脏中 FGF8 的生理受体,配体主要与受体的 Ig2 结构域结合。通过 Biacore 实验,我们还测量了 FGF8 与不同构建体的亲和力。所有含有 Ig2 结构域的构建体均显示快速缔合和缓慢解离相,由此计算出 K 值为 2-3×10^-9 M。我们的数据支持这样一种假设,即 FGF8 与 FGFRL1 的结合可能在驱动发育中肾脏的肾单位形成中起重要作用。